Memantin Basics (Memantine Hydrochloride)

Memantine works by blocking the NMDA‑type glutamate receptors in the brain. This non‑competitive antagonism reduces excessive calcium entry into neurons, limiting excitotoxic damage that contributes to the cognitive decline seen in Alzheimer’s disease.

The appropriate dose of Memantin Basics is determined by the prescribing clinician based on the patient’s condition, renal function, and tolerability. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for memantine in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order Memantin Basics, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantine belongs to the NMDA‑receptor antagonist class, whereas many other Alzheimer’s treatments are cholinesterase inhibitors (e.g., donepezil). Memantine is typically used for moderate to severe disease and may be combined with a cholinesterase inhibitor for additive benefit.

Store Memantin Basics at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Memantin Basics is taken orally. The tablets should be swallowed whole with water, preferably with or without food, as directed by the prescribing physician.

Serious risks include the possibility of seizures, severe skin reactions such as Stevens‑Johnson syndrome, hepatic injury, cardiac arrhythmias, and emergent psychiatric symptoms like suicidal thoughts or psychosis. Any of these should prompt immediate medical attention.

Memantin Basics should not be used by individuals with known hypersensitivity to memantine or any of its excipients, and it is contraindicated in patients with severe renal impairment unless dose adjustments are made. Caution is also advised for patients with a history of seizures or significant cardiac disease.